Association of Circulating Neutrophils with Relative Volume of Lipid-Rich Necrotic Core of Coronary Plaques in Stable

Silverio Sbrana1, Antonella Cecchettini2,3, Luca Bastiani1

  • 1CNR Institute of Clinical Physiology, 54100 Massa, Italy.

Life (Basel, Switzerland)
|February 25, 2023
PubMed

Insights

Increased circulating neutrophils and CD11b expression correlate with larger lipid-rich necrotic core volumes in coronary plaques, indicating higher vulnerability in stable coronary artery disease patients.

Area of Science:

  • Cardiovascular immunology
  • Atherosclerosis research
  • Platelet-neutrophil interactions

Background:

  • Coronary atherosclerosis involves chronic inflammation with key roles for innate immune cells and platelets.
  • Neutrophils adhere to endothelium, migrate into vascular walls, and influence plaque phenotype and stability.
  • Lipid-rich necrotic core volume (LRNCV) is a key indicator of coronary plaque vulnerability.

Purpose of the Study:

  • To evaluate the association between blood neutrophil counts and phenotypes with LRNCV in stable chronic coronary syndrome (CCS) patients.
  • To assess neutrophil relationships with platelets, monocytes, and lymphocytes in relation to plaque vulnerability.
  • To determine if neutrophil markers correlate with LRNCV, a measure of coronary plaque instability.

Main Methods:

  • Quantitative analysis of LRNCV from computed tomography coronary angiography (CTCA) in 55 patients.
  • Flow cytometry to quantify cell surface markers (CD14, CD16, CD11b, CD41a, etc.) on neutrophils, platelets, monocytes, and lymphocytes.
  • ELISA to measure plasma levels of adhesion molecules, cytokines, chemokines, and MMP9.

Main Results:

  • LRNCV positively associated with neutrophil count, neutrophil/lymphocyte ratio, and neutrophil/platelet ratio.
  • Neutrophil CD11b expression and neutrophil-platelet adhesion index showed significant positive associations with LRNCV.
  • Significant associations found between LRNCV and phenotypic ratios involving neutrophil CD11b expression and lymphocyte/monocyte markers.

Conclusions:

  • Elevated circulating neutrophils and CD11b expression may enlarge the lipid-rich necrotic core volume in coronary plaques.
  • This process could result from impaired efferocytosis and anti-inflammatory capacity of macrophages and lymphocytes.
  • Findings suggest increased plaque vulnerability and risk of acute complications in stable coronary artery disease patients.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
20
Inflammation01:38

Inflammation

Overview
54.3K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
31
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
19
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
134
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
29